Comparative oncology approach to drug repurposing in osteosarcoma.
Autorzy:
Parrales A; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, United States of America. McDonald P; High Throughput Screening Laboratory, University of Kansas Cancer Center, University of Kansas, Lawrence, Kansas, United States of America. Ottomeyer M; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, United States of America. Roy A; High Throughput Screening Laboratory, University of Kansas Cancer Center, University of Kansas, Lawrence, Kansas, United States of America.; University of Kansas Cancer Center, Kansas City, Kansas, United States of America. Shoenen FJ; University of Kansas Cancer Center, Kansas City, Kansas, United States of America.; Biotechnology Innovation and Optimization Center, University of Kansas, Lawrence, Kansas, United States of America. Broward M; University of Kansas Cancer Center, Kansas City, Kansas, United States of America.; Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, Kansas, United States of America. Bruns T; Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, Kansas, United States of America. Thamm DH; Flint Animal Cancer Center, Colorado State University, Fort Collins, Colorado, United States of America.; University of Colorado Comprehensive Cancer Center, Aurora, Colorado, United States of America. Weir SJ; University of Kansas Cancer Center, Kansas City, Kansas, United States of America.; Institute for Advancing Medical Innovation, University of Kansas Medical Center, Kansas City, Kansas, United States of America.; Department of Pediatrics, University of Missouri Kansas City, Kansas City, Missouri, United States of America.; Department of Pharmacology, Toxicology and Therapeutics, University of Kansas, Kansas City, Kansas, United States of America. Neville KA; Arkansas Children's Hospital, Little Rock, Arkansas, United States of America. Iwakuma T; Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, United States of America.; University of Kansas Cancer Center, Kansas City, Kansas, United States of America.; Division of Hematology and Oncology, Children's Mercy Hospital and Clinics, Kansas City, Missouri, United States of America. Fulbright JM; University of Kansas Cancer Center, Kansas City, Kansas, United States of America.; Department of Pediatrics, University of Missouri Kansas City, Kansas City, Missouri, United States of America.; Division of Hematology and Oncology, Children's Mercy Hospital and Clinics, Kansas City, Missouri, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2018 Mar 26; Vol. 13 (3), pp. e0194224. Date of Electronic Publication: 2018 Mar 26 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
